We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

176 hedge funds and large institutions have $1.58B invested in Intra-Cellular Therapies Inc. in 2020 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 71 increasing their positions, 39 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

135% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 20

82% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 39

28% more call options, than puts

Call options by funds: $38.2M | Put options by funds: $29.7M

27% more capital invested

Capital invested by funds: $1.25B → $1.58B (+$332M)

18% more funds holding

Funds holding: 149 → 176 (+27)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
176
Holders Change
+27
Holders Change %
+18.12%
% of All Funds
3.55%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
47
Increased
71
Reduced
39
Closed
20
Calls
$38.2M
Puts
$29.7M
Net Calls
+$8.46M
Net Calls Change
-$41.4M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$75.5M
2
Millennium Management
Millennium Management
New York
+$41.3M
3
WA
Wasatch Advisors
Utah
+$39.9M
4
Marshall Wace
Marshall Wace
United Kingdom
+$38.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$21.9M

Top Sellers

Rank Fund Capital Flow
1
SLT
St Louis Trust
Missouri
-$22.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$14.8M
3
Goldman Sachs
Goldman Sachs
New York
-$10.1M
4
Norges Bank
Norges Bank
Norway
-$6.08M
5
BG
Bellevue Group
Switzerland
-$4.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
51
Polar Capital
United Kingdom
$3.85M +$3.42M +150,000 New
PVI
52
Pura Vida Investments
New York
$3.85M +$3.42M +150,000 New
Goldman Sachs
53
Goldman Sachs
New York
$3.74M -$10.1M -440,513 -75%
Barclays
54
Barclays
United Kingdom
$3.67M +$1.2M +52,394 +58%
B
55
Bailard
California
$3.39M -$205K -9,000 -6%
California Public Employees Retirement System
56
California Public Employees Retirement System
California
$3.28M +$143K +6,250 +5%
SM
57
Sabby Management
Florida
$2.95M +$2.62M +115,000 New
PCM
58
Pinz Capital Management
New York
$2.6M +$2.31M +101,400 New
State of Wisconsin Investment Board
59
State of Wisconsin Investment Board
Wisconsin
$2.59M +$214K +9,400 +10%
IHAM
60
Integral Health Asset Management
New York
$2.57M +$2.28M +100,000 New
DCM
61
Driehaus Capital Management
Illinois
$2.56M +$2.27M +99,644 New
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
$2.54M +$365K +15,995 +19%
AllianceBernstein
63
AllianceBernstein
Tennessee
$2.43M +$146K +6,400 +7%
TCM
64
Tekla Capital Management
Massachusetts
$2.42M – – –
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$2.29M -$258K -11,303 -11%
Wells Fargo
66
Wells Fargo
California
$2.17M +$712K +31,188 +59%
ECM
67
ExodusPoint Capital Management
New York
$2.16M +$1.92M +84,027 New
SG Americas Securities
68
SG Americas Securities
New York
$2.11M +$1.16M +51,040 +164%
Ohio Public Employees Retirement System (OPERS)
69
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.09M +$392K +17,179 +27%
New York State Common Retirement Fund
70
New York State Common Retirement Fund
New York
$1.88M +$498K +21,810 +42%
Bank of America
71
Bank of America
North Carolina
$1.86M +$118K +5,163 +8%
Jane Street
72
Jane Street
New York
$1.77M -$3.63M -159,174 -70%
CL
73
CSS LLC
Illinois
$1.67M +$892K +39,101 +151%
AIM
74
Aigen Investment Management
New York
$1.66M +$1.47M +64,625 New
CM
75
Caption Management
Oklahoma
$1.53M +$151K +6,623 +12%
1 2
3
4 5

ITCI Hedge Fund Activity: Q3 2020 in Review

176 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q3 2020, worth a combined $1.58B — up 27% from $1.25B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new ITCI positions and 20 closed out — a net gain of 27 holders — while 71 added to existing stakes and 39 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $75.5M. The largest seller was St Louis Trust, exiting entirely with an estimated $22.6M sold.

  • 176 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q3 2020, up from 149 in Q2 2020.
  • Funds reported $1.58B of Intra-Cellular Therapies Inc. stock for Q3 2020, up 27% quarter-over-quarter.
  • 47 funds opened new Intra-Cellular Therapies Inc. positions in Q3 2020 and 20 closed out, a net change of +27 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q3 2020 was Fidelity Investments, an estimated $75.5M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q3 2020 was St Louis Trust, an estimated $22.6M sold.

Based on aggregated 13F filings for Q3 2020.